Trajan Scientific and Medical (Trajan) and the University of Melbourne have embarked on an investigative collaboration today in the fields of molecular pathology and skin cancer diagnostics.
Molecular testing techniques can be used to pursue more accurate cancer screening and disease diagnosis.
Trajan’s emerging tools in micro sampling, sample preparation and mass spectrometry interfaces have generated strong interest in these healthcare applications.
Eight Master of Biotechnology students from the University’s Faculty of Science will be undertaking two industry projects in these areas, with guidance from Trajan mentors Mr Paul Romeo, General Manager, Australia and New Zealand, and Mr Stephen Tomisich, Chief Executive Officer.
"We look forward to fresh insights from the teams, which will help shape Trajan’s roadmap for diagnostic technologies.” said Mr Tomisich.
Academic and industry partnerships are key to Trajan’s collaborative model for innovation, accelerating delivery of scientific and medical solutions to the market that will make a positive impact on human wellbeing.
Photo (L-R): The University of Melbourne student teams at Trajan Global Headquarters in Melbourne, Australia. Paul Romeo (General Manager, Australia and New Zealand, Trajan), Keerthi Kalyan Kothapally, Seumas Shu Men Teh, Angela Tomisich (General Manager, Microscopy Products, Trajan), Robert Lyon (Head of Corporate Development, Trajan), Elpis Barons (General Manager, Accelerator Group, Trajan), Fiona Simpson (Careers and Industry Consultant, The University of Melbourne), Dr Andrew Gooley (Chief Scientific Officer, Trajan), Benjamin Nicholas Le Couteur, Belinda Bich Thuy Thieu Quang, Yanling Wu, Kairui Li, Jie Dong, Jingran Zhang, Rhonda Gailey (Assistant Manager, Corporate Development, Trajan), Dr Matthew Digby (Subject Coordinator, The University of Melbourne), Stephen Tomisich (Chief Executive Officer, Trajan).
Pathology in Practice looks into a simple but effective solution to stop tissue sections becoming detached and floating away when faced with harsh processing conditions typical of methods such as immunohistochemistry and in situ hybridization.